Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr:76:103434.
doi: 10.1016/j.amsu.2022.103434. Epub 2022 Mar 3.

COVID-19 associated with pulmonary mucormycosis; a case series

Okba F Ahmed  1 , Saoud Al-Neaimy  2 , Fahmi H Kakamad  3   4   5 , Razhan K Ali  6 , Tomas M Mikael  3   5 , Ahmed Gh Hamasaeed  3   7 , Shvan H Mohammed  5 , Rawezh Q Salih  3   5 , Abdulwahid M Salh  3   4 , Muhammed Gh Hamasaeed  4
Affiliations

COVID-19 associated with pulmonary mucormycosis; a case series

Okba F Ahmed et al. Ann Med Surg (Lond). 2022 Apr.

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) has evolved as a result of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). With the rise of cases worldwide, plenty of potential COVID-19 complications have emerged, including increased susceptibility to subsequent bacterial and fungal infections. This study aims to report four cases of COVID-19 associated with pulmonary mucormycosis.

Method: This is a multi-center case series study. Diagnosis of COVID-19 was confirmed by reverse transcriptase-polymerase chain reaction.

Result: A total of 4 patients infected with SARS-CoV2 were involved in this study. The majority of the cases were female, aged >42 years old. All patients developed severe symptoms. All of the patients had received steroids, half of them had co-morbidities. The most common computerized tomography (CT) scan findings were pulmonary cavitation and empyema. All of the cases were treated with a combination of surgery and antifungal treatment.

Conclusion: As the number of COVID-19 cases rises, enhanced surveillance for co-infections with unusual pathogens should be continued. Clinicians should raise awareness of these deadly infections, which can further aggravate severe COVID-19.

Keywords: COVID-19; Fungal infection; Mucormycosis; Pulmonary complication; SARS-CoV2.

PubMed Disclaimer

Conflict of interest statement

There is no conflict to be declared.

References

    1. Ahmad S.A., Salih K.H., Ahmed S.F., Kakamad F.H., Salih A.M., Hassan M.N., et al. Post COVID-19 transverse myelitis; a case report with review of literature. Ann. Med. Surg. 2021:102749. - PMC - PubMed
    1. Desai E.J., Pandya A., Upadhya I., Patel T., Banerjee S., Jain V. Epidemiology, clinical features and management of rhino orbital mucormycosis in post COVID 19 patients. Indian J. Otolaryngol. 2021:1–5. - PMC - PubMed
    1. World Health Organization 2020. https://covid19.who.int/ September 5.
    1. Kakamad F.H., Mahmood S.O., Rahim H.M., Abdulla B.A., Abdullah H.O., Othman S., et al. Post covid-19 invasive pulmonary Aspergillosis: a case report. Int. J. Surg. Case Rep. 2021;82:105865. - PMC - PubMed
    1. Baram A., Kakamad F.H., Abdullah H.M., Mohammed-Saeed D.H., Hussein D.A., Mohammed S.H., et al. Large vessel thrombosis in patient with COVID-19, a case series. Ann. Med. Surg. 2020;60:526–530. - PMC - PubMed